Singapore markets closed
  • Straits Times Index

    3,071.23
    +6.69 (+0.22%)
     
  • Nikkei

    30,500.05
    +176.71 (+0.58%)
     
  • Hang Seng

    24,920.76
    +252.91 (+1.03%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • BTC-USD

    48,235.73
    +693.91 (+1.46%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • FTSE Bursa Malaysia

    1,548.51
    -6.75 (-0.43%)
     
  • Jakarta Composite Index

    6,133.25
    +23.30 (+0.38%)
     
  • PSE Index

    6,912.85
    -55.58 (-0.80%)
     

Sight Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) today announced it will report financial results for the second quarter 2021 after the market close on Thursday, August 12, 2021. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://investors.sightsciences.com/.

About Sight Sciences
Founded in 2011, Sight Sciences is a growth stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases. The company currently markets two products, the OMNI® Surgical System and the TearCare® System. For more information, visit www.sightsciences.com.

OMNI® and TearCare® are registered trademarks of Sight Sciences.
© 2021 Sight Sciences. All rights reserved.

Media contact:
Shay Smith
Health+Commerce
707.971.9779
shay@healthandcommerce.com

Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
Investor.Relations@Sightsciences.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting